Skip to content

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Acupuncture For Prevention Of Postoperative Nausea And Vomiting In Patients Undergoing Laparoscopic Cholecystectomy - A Randomized Controlled Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05975385
Enrollment
270
Registered
2023-08-03
Start date
2023-10-09
Completion date
2026-02-10
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis, Acute, Cholelithiasis, Nausea, Postoperative, Pain, Postoperative, Vomiting, Postoperative

Brief summary

The purpose is to find out if intraoperative acupuncture performed by needling PC 6 and LI4 point bilaterally, and Yin Tang point will help reduce the incidence postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when added to a prophylactic regimen consisting of ondansetron and dexamethasone. The hypothesis is that the addition of this acupuncture treatment to ondansetron and dexamethasone given for prophylaxis will help reduce the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when compared to patients receiving ondansetron and dexamethasone without acupuncture.

Interventions

DEVICEAcupuncture

Acupuncture at points points PC 6 bilaterally, LI 4 bilaterally, and Yin Tang

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patient will be under general anesthesia when treatment provided. They will not know whether or not they received acupuncture treatment. Postoperative assessors will not know which group the patient is in.

Intervention model description

Randomized controlled trial. Group 1 - Acupuncture Group 2 - No acupuncture

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

1. Patient ages 18-64 2. American Society of Anesthesiology Physical Status I, II or III 3. Patients scheduled to undergo laparoscopic cholecystectomy at Harris Health System Ben Taub Hospital

Exclusion criteria

1. Scheduled open cholecystectomy - excluded due to increased levels of pain in open procedures 2. Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential altered metabolism of anesthetic and perioperative medications 3. Allergy to any of the standard anesthetic agents 4. Patient inability to properly communicate with investigators (language barrier, dementia, delirium, psychiatric disorder) 5. Patient or surgeon refusal

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative nausea and vomitingPostoperative: 0-1 hours, 1-6 hours, 6-12 hours, 12-24 hoursIncidence of nausea and vomiting after surgery

Secondary

MeasureTime frameDescription
Postoperative pain24 hoursPain on scale 1-10 measured on arrival to PACU, discharge from PACU and at 24 hours post surgery
Total opioids used24 hoursTotal opioid given, converted to oral morphine equivalents

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026